Envista Holdings NVST
NYSE NVST
$23.06 +0.09 (+0.37%)
As of: Oct 21, 2026 · 2:12 PM EDT

Envista Holdings (NVST) Cash from Restructuring (2023 - 2026)

Updated

Analysis

Envista Holdings (NVST) Cash from Restructuring (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.72 Bn 236.75 Bn 4.88 Bn
2 Abbott Laboratories 171.68 Bn 142.11 Bn 7.27 Bn
3 Danaher 162.45 Bn 146.25 Bn 3.61 Bn
4 Intuitive Surgical 152.26 Bn 131.69 Bn 1.96 Bn
5 Medtronic 119.62 Bn 84.87 Bn 6.34 Bn
6 Stryker 113.98 Bn 100.09 Bn 4.50 Bn
7 Boston Scientific 65.62 Bn 60.39 Bn 3.85 Bn
8 Becton Dickinson 53.58 Bn 50.73 Bn 2.32 Bn
9 Edwards Lifesciences 50.91 Bn 34.92 Bn 1.35 Bn
10 Envista Holdings 3.73 Bn -821.40 Mn 407.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 900,000.00
Mar 28, 2025 200,000.00
Jun 28, 2024 200,000.00
Mar 29, 2024 -200,000.00
Dec 31, 2023 600,000.00
Sep 29, 2023 -100,000.00
Jun 30, 2023 700,000.00
Mar 31, 2023 100,000.00
API Access

Envista Holdings Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=NVST&period=max&api_key=YOUR_API_KEY